Xtant Medical Holdings, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in 2007, the company has established itself as a leader in the development and distribution of innovative spinal and cranial surgical solutions. With a focus on regenerative medicine, Xtant Medical offers a range of core products, including allograft tissue and advanced surgical instruments, designed to enhance patient outcomes. Operating primarily in North America, Xtant Medical has achieved significant milestones, including strategic acquisitions that have expanded its product portfolio and market reach. Renowned for its commitment to quality and innovation, the company continues to strengthen its position in the competitive landscape of orthopaedic and neurosurgical markets, making it a trusted partner for healthcare professionals worldwide.
How does Xtant Medical Holdings, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc.'s score of 20 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Xtant Medical Holdings, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company, suggesting a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Xtant Medical Holdings, Inc. aligns with industry standards for climate action. The company does not appear to inherit any emissions data from a parent organisation, nor does it participate in initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP) that could provide further insights into its climate commitments. In summary, Xtant Medical Holdings, Inc. has not disclosed any carbon emissions or reduction targets, leaving a gap in its climate commitment profile.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Xtant Medical Holdings, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.